Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

Cautionary Language Concerning Forward-Looking Statements ...

Medically reviewed by Aviv Joshua, MS, RDN Kefir, often described as a "drinkable yogurt," is a fermented milk drink rich in ...

Scottish Medicines Consortium approves new NHS Scotland drugs for lung cancer, leukaemia, cervical cancer, pulmonary ...

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the pulmonary arteries, which transport blood from the heart to the lungs. This can ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Last week, GSK agreed to acquire Canadian biotech 35Pharma for $950 million, adding a new pulmonary hypertension program to its respiratory and cardiopulmonary pipeline. The deal is built around HS235 ...

Early signs of pulmonary hypertension are relatively mild and mimic common conditions such as asthma, poor fitness or anxiety. [Courtesy] Many people are familiar with hypertension, commonly described ...

Early diagnosis of pulmonary arterial hypertension (PAH), less than six months after symptom onset, improves five-year survival by 42% compared with delayed diagnosis of about two years or more, a ...